Interesting Endo: Obesity and Osteoporosis

July 14, 2017

Browse new research on: diabetes agents preferred in osteoporosis patients, an alternative to BMI, and interventions that work for pediatric obesity.

Click through the slides above for our monthly at-a-glance reviews of recent studies in endocrinology. Among our July topics:Â Â â¦ The best antidiabetes agents for bone healthÂ â¦ WHI data on bisphosphonate useÂ â¦ Impact of prebiotics on visceral fat in pediatric patientsSee the slide legends for links to the article summaries.

Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management. Abstract link.

Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women’s Health Initiative. Abstract link.

Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Abstract link.

Child Body Mass Index, Genotype and Parenting in the Prediction of Restrictive Feeding. Abstract link.

Prediction of Whole-Body Fat Percentage and Visceral Adipose Tissue Mass From Five Anthropometric Variables. Abstract link.

Prebiotic Reduces Body Fat and Alters Intestinal Microbiota in Children With Overweight or Obesity. Abstract link.

Effect of Omega-3 Supplementation on Neuropathy in Type 1 Diabetes: A 12-Month Pilot Trial. Abstract link.

An Additional Bolus of Rapid-Acting Insulin to Normalise Postprandial Cardiovascular Risk Factors Following a High-Carbohydrate High-Fat Meal in Patients With Type 1 Diabetes: A Randomised Controlled Trial. Abstract link.

Related Content:

Interesting Endo: Obesity and Osteoporosis

Julie Bowen